Express Pharma

JANUARY 14, 2024

Recombinant technology is the manipulation of the host genome by adding a foreign altered gene vector to produce new genetic combinations that are of value to science, health, and industry. Here, the introduced gene vector is the recombinant gene, usually added to change the phenotype of an organism. To achieve genetically modified organisms (GMOs), isolation of pure DNA, cutting at recognised locations of DNA to get the desired gene, amplification of the desired gene using polymerase chain reac

Documentation 116

Documentation 116

The Guardian - Pharmaceutical Industry

JANUARY 14, 2024

Four people with conditions that require consistent medication explain how the shortages have affected their wellbeing NHS medicines shortage putting people at risk, pharmacists warn Analysis: why is UK being hit by medicine supply shortages? More people in the UK are struggling to access vital medicines than ever before, exacerbating conditions from epilepsy to the menopause.

109

109

Express Pharma

JANUARY 14, 2024

ENTOD Pharmaceuticals has launched ‘FUR’, a division to provide eye and ear care medicines for pets. The product portfolio of FUR by ENTOD encompasses a wide range of veterinary eye and ear care solutions, from lubricating drops to anti-glaucoma medications, anti-allergies, antibiotics, and combinations. FUR by ENTOD products is set to be available not only in the domestic market but also to their international partners and customers.

100

100

The Guardian - Pharmaceutical Industry

JANUARY 14, 2024

Unpublished figures reveal a doubling of products in short supply over past two years ‘The worst I’ve known it’: the struggle to get vital medicines Analysis: why is UK being hit by medicine supply shortages? An unprecedented medicines shortage in the NHS is endangering lives, pharmacists have said, as unpublished figures reveal that the number of products in short supply has doubled in two years.

Diabetes 111

Diabetes 111

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

pharmaphorum

JANUARY 14, 2024

FDA has opened a comment period until January 31 on how digital health technologies (DHTs) may be deployed to help prevent, detect and manage diabetes

Diabetes 99

Diabetes 99

Drug Patent Watch

JANUARY 14, 2024

This chart shows the pharmaceutical companies with the most cream dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most cream dosed drugs… The post Which pharmaceutical companies have the most cream dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Dosage 59

Drug Patent Watch

JANUARY 14, 2024

Annual Drug Patent Expirations for NUPLAZID Nuplazid is a drug marketed by Acadia Pharms Inc and is included in two NDAs. It is available from one supplier. There are fourteen… The post New patent expiration for Acadia Pharms drug NUPLAZID appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Pharmacy Joe

JANUARY 14, 2024

In this episode, I’ll discuss a pre-planned analysis of long term outcomes of haloperidol use in the Agents Intervening against Delirium in the ICU Trial. Episode 887: Long Term Outcomes of Haloperidol Use in the Agents Intervening against Delirium in the ICU Trial Subscribe on iTunes , Android , or Stitcher Back in episode 762 I discussed the AID-ICU trial which was a placebo-controlled randomized blinded trial of 1000 patients with ICU delirium published in NEJM.

Inpatient 52

Inpatient Hospitals 52

Drug Patent Watch

JANUARY 14, 2024

Annual Drug Patent Expirations for SECUADO Secuado is a drug marketed by Hisamitsu and is included in one NDA. It is available from one supplier. There are five patents protecting… The post New patent for Hisamitsu drug SECUADO appeared first on DrugPatentWatch - Make Better Decisions.

59

59

PharmaState Academy

JANUARY 14, 2024

Episode 22 - Pharma Journey of Parul Sood | Humans of Pharma In Episode 22 of the Pharma Journey Series, we will get to know more about the inspirational journey of Ms. Parul Sood. With over a decade and a half of prolific experience in pharmaceutical sales and marketing. She embodies the epitome of confidence, ambition, and performance-driven leadership within the dynamic realm of healthcare.

Biosimilars 52

Biosimilars 52

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Drug Patent Watch

JANUARY 14, 2024

Annual Drug Patent Expirations for AUGTYRO Augtyro is a drug marketed by Bristol and is included in one NDA. It is available from one supplier. The generic ingredient in AUGTYRO… The post New patent for Bristol drug AUGTYRO appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Med Ed 101

JANUARY 14, 2024

Fenofibrate is a lipid-lowering medication indicated as monotherapy to treat primary hyperlipidemia, mixed dyslipidemia, and hypertriglyceridemia. While this medication has been around for many years, its formulation has continued to evolve. The different fenofibrate formulations can get confusing, especially when terms such as micronized, nanoparticles, and solid dispersions get thrown into the mix.

52

52

Drug Patent Watch

JANUARY 14, 2024

Annual Drug Patent Expirations for EPRONTIA Eprontia is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are two patents protecting… The post New patent for Azurity drug EPRONTIA appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Pharmaceutical Business Review

JANUARY 14, 2024

This agreement focuses on treating fourth-line gastrointestinal stromal tumours (GIST) in adult patients. The territories covered under the deal include Croatia, Bulgaria, Czech Republic, Cyprus, Greece, Estonia, Latvia, Lithuania, Hungary, Malta, Romania, Poland, Slovakia, and Slovenia. A switch-control inhibitor of Deciphera, Ripretinib is approved in the EU for adults with advanced GIST.

59

59

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Drug Patent Watch

JANUARY 14, 2024

Annual Drug Patent Expirations for DIFICID Dificid is a drug marketed by Cubist Pharms Llc and is included in two NDAs. It is available from one supplier. There are six… The post New patent expiration for Cubist Pharms drug DIFICID appeared first on DrugPatentWatch - Make Better Decisions.

59

59